Last reviewed · How we verify
NCT03930511: SmartReab
Telemonitoring Physical Activity in Daily Life on Chronic Respiratory Patients
NA trial testing Pulmonary Rehabilitation in Chronic Respiratory Disease in 100 participants. Completed in 30 October 2019.
31 October 2018
Quick facts
| Lead sponsor | University of Lisbon |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 100 |
| Start date | 18 January 2017 |
| Primary completion | 31 October 2018 |
| Estimated completion | 30 October 2019 |
| Sites | 2 locations across Portugal |
Drugs / interventions tested
- Pulmonary Rehabilitation
Conditions studied
- Chronic Respiratory Disease — all drugs for Chronic Respiratory Disease →
Sponsor
University of Lisbon
Who can join
Eligibility, any sex, with Chronic Respiratory Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Physical inactivity is a consequence of chronic diseases and on Chronic Obstructive Pulmonary Disease patients is an independent predictor of the risk of hospitalizations and early mortality. As physical inactivity is a modifiable risk factor with healthy lifestyle interventions, health professionals should clinically assess physical activity as a vital sign of patients' general physical condition. SmartReab study aims to characterize physical activity in daily life of 100 chronic respiratory patients at baseline when starting Pulmonary Rehabilitation, at discharge time of the program, at 6 months and 1 year follow-up. The Pulmonary Rehabilitation program will be individually tailored according to patients needs and goals settled within the Rehabilitation team and it will take place at Hospital Pulido Valente, from Centro Hospitalar Universitário Lisboa Norte, in Lisbon, Portugal. To access physical activity in daily life patients will participate in a telemonitoring study for 4 days using a smartphone and an oximeter and also answer to the International Physical Activity Questionnaire. SmartReab technology will provide data of physical activity intensity, heart rate and oxygen levels during awakening periods of daytime. To associate physical activity with other aspects related with health and the impact of Pulmonary Rehabilitation, patients will also take a 6 minute walk test and answer questionnaires related with self-perceived health status, impact of respiratory symptoms on quality of life, dyspnea impact on general mobility and on daily life situations, and also anxiety and depression feelings. The research hypothesis is that Pulmonary Rehabilitation will have a positive impact on physical activity in the short, medium and long terms.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Telemonitoring of daily activities compared to the six-minute walk test further completes the puzzle of oximetry-guided interventions.
Santos CD, Santos AF, das Neves RC, Ribeiro RM, et al · · 2021 · cited 10× · PMID 34400715 · DOI 10.1038/s41598-021-96060-w -
Novel Input for Designing Patient-Tailored Pulmonary Rehabilitation: Telemonitoring Physical Activity as a Vital Sign-SMARTREAB Study.
Santos CD, das Neves RC, Ribeiro RM, Caneiras C, et al · · 2020 · cited 5× · PMID 32751825 · DOI 10.3390/jcm9082450
Verify or expand the search:
- PubMed search for NCT03930511
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Pulmonary Rehabilitation
Trials testing the same drug.
- NCT07197229 — Hospital- and Home-Based Structured Pulmonary Rehabilitation in Recently Admitted COPD Patients: A Quasi-Experimental St · NA · not yet recruiting
- NCT07376161 — Inflammation and Oxidative Stress in COPD · enrolling by invitation
- NCT07097961 — Paediatric Post-TB Pulmonary Rehab Study · NA · recruiting
- NCT06756230 — Downhill Walking in IPF · NA · recruiting
- NCT06707623 — CPET Guided Rehab vs Physiotherapy in Patients With Dysfunctional Breathing · NA · recruiting
Other recruiting trials for Chronic Respiratory Disease
Currently open trials in the same condition.
- NCT06579612 — The Benefits of Individualized Follow-up With a Sport-Health Professional in the Care of Patients With Chronic Respirato · NA · recruiting
- NCT06459011 — TAKINGCARE - TAcKlING the Needs of Carers of People With Chronic respirAtoRy disEases · recruiting
- NCT06525857 — Observing Physiological Changes in Patients With Long-term Oxygen Therapy · recruiting
- NCT05820776 — Tele-rehabilitation in Chronic Respiratory Disease: an Observational Cohort Study · recruiting
- NCT05248412 — The Long-term Spill-over Impact of COVID-19 on Health and Healthcare of People With Non-communicable Diseases · recruiting
Other University of Lisbon trials
Trials by the same sponsor.
- NCT07276191 — UL Smile: A Mobile Health Application to Promote Oral Health in Portuguese Adolescents · NA · recruiting
- NCT06760663 — The Load-velocity Relationship: Neuromuscular Adaptations to Resistance Training · NA · completed
- NCT05798299 — Efficacy Study of a Child-centered Version of the Unified Protocol for the Transdiagnostic Treatment of Emotional Disord · NA · unknown
- NCT05436002 — Treatment of Buccal Ginvigal Recessions With the Tunnel Technique in Conjunction With Cross-linked Hyaluronic Acid and S · NA · unknown
- NCT05179746 — Adjunctive Benefit of Electrolytic Cleaning on Non-surgical Treatment of Peri-implantitis. · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03930511 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Lisbon
- Last refreshed: 10 November 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03930511.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing